Thus, the purpose of this work was to evaluate the antitumoral activity of GANT61, a downstream inhibitor of the HH pathway, on the gene and protein expression of HH pathway components (PTCH1, GLI1, GLI2, and GLI3), as well as tumor cell proliferation and death in a metastatic OSCC cell line. The gene discussed is GLI3; the disease is neoplasm.